• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP47 的结构与功能表征揭示了抑制剂设计的热点。

Structural and functional characterization of USP47 reveals a hot spot for inhibitor design.

机构信息

Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.

Research Resources Division, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.

出版信息

Commun Biol. 2023 Sep 22;6(1):970. doi: 10.1038/s42003-023-05345-5.

DOI:10.1038/s42003-023-05345-5
PMID:37740002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10516900/
Abstract

USP47 is widely involved in tumor development, metastasis, and other processes while performing a more regulatory role in inflammatory responses, myocardial infarction, and neuronal development. In this study, we investigate the functional and biochemical properties of USP47, whereby depleting USP47 inhibited cancer cell growth in a p53-dependent manner-a phenomenon that enhances during the simultaneous knockdown of USP7. Full-length USP47 shows higher deubiquitinase activity than the catalytic domain. The crystal structures of the catalytic domain, in its free and ubiquitin-bound states, reveal that the misaligned catalytic triads, ultimately, become aligned upon ubiquitin-binding, similar to USP7, thereby becoming ready for catalysis. Yet, the composition and lengths of BL1, BL2, and BL3 of USP47 differ from those for USP7, and they contribute to the observed selectivity. Our study provides molecular details of USP47 regulation, substrate recognition, and the hotspots for drug discovery by targeting USP47.

摘要

USP47 广泛参与肿瘤发生、转移和其他过程,同时在炎症反应、心肌梗死和神经元发育中发挥更具调节作用。在这项研究中,我们研究了 USP47 的功能和生化特性,通过耗尽 USP47 以依赖 p53 的方式抑制癌细胞生长,这种现象在同时敲低 USP7 时会增强。全长 USP47 显示出比催化结构域更高的去泛素化酶活性。催化结构域的晶体结构,无论是在自由状态还是与泛素结合状态,都表明未对齐的催化三联体最终在结合泛素后对齐,类似于 USP7,从而为催化做好准备。然而,USP47 的 BL1、BL2 和 BL3 的组成和长度与 USP7 不同,它们有助于观察到的选择性。我们的研究提供了 USP47 调节、底物识别以及通过靶向 USP47 进行药物发现的热点的分子细节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/c1ee62b28ac9/42003_2023_5345_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/98c28cbc116f/42003_2023_5345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/deff1eba1a3a/42003_2023_5345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/8ab7b87f7460/42003_2023_5345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/f7858b2aa4b4/42003_2023_5345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/7611c71252c1/42003_2023_5345_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/c1ee62b28ac9/42003_2023_5345_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/98c28cbc116f/42003_2023_5345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/deff1eba1a3a/42003_2023_5345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/8ab7b87f7460/42003_2023_5345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/f7858b2aa4b4/42003_2023_5345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/7611c71252c1/42003_2023_5345_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054e/10516900/c1ee62b28ac9/42003_2023_5345_Fig6_HTML.jpg

相似文献

1
Structural and functional characterization of USP47 reveals a hot spot for inhibitor design.USP47 的结构与功能表征揭示了抑制剂设计的热点。
Commun Biol. 2023 Sep 22;6(1):970. doi: 10.1038/s42003-023-05345-5.
2
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation.USP7 和 USP47 去泛素化酶调节 NLRP3 炎症小体的激活。
EMBO Rep. 2018 Oct;19(10). doi: 10.15252/embr.201744766. Epub 2018 Sep 11.
3
Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases.泛素特异性蛋白酶47在癌症及其他疾病中的作用
Front Cell Dev Biol. 2021 Sep 17;9:726632. doi: 10.3389/fcell.2021.726632. eCollection 2021.
4
Expression, purification and enzymatic characterization of a recombinant human ubiquitin-specific protease 47.重组人泛素特异性蛋白酶47的表达、纯化及酶学特性分析
J Biochem. 2015 Dec;158(6):477-84. doi: 10.1093/jb/mvv063. Epub 2015 Jun 26.
5
Ubiquitin specific peptidase 47 promotes proliferation of lung squamous cell carcinoma.泛素特异性肽酶 47 促进肺鳞癌细胞的增殖。
Genes Genomics. 2022 Jun;44(6):721-731. doi: 10.1007/s13258-022-01233-0. Epub 2022 Mar 7.
6
USP7 small-molecule inhibitors interfere with ubiquitin binding.USP7 小分子抑制剂会干扰泛素结合。
Nature. 2017 Oct 26;550(7677):534-538. doi: 10.1038/nature24006. Epub 2017 Oct 18.
7
Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.蛋白质组学分析揭示了泛素特异性蛋白酶 (USP47) 在 TGFβ2 诱导的乳腺细胞上皮间质转化 (EMT)中的作用。
J Proteomics. 2020 May 15;219:103734. doi: 10.1016/j.jprot.2020.103734. Epub 2020 Mar 19.
8
USP7 interacts with and destabilizes oncoprotein SET.泛素特异性蛋白酶7与癌蛋白SET相互作用并使其不稳定。
Biochem Biophys Res Commun. 2024 May 21;709:149818. doi: 10.1016/j.bbrc.2024.149818. Epub 2024 Mar 27.
9
Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase.人类疱疹病毒8型干扰素调节因子1和3通过与USP7去泛素化酶相互作用介导复制和潜伏活性。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.02003-17. Print 2018 Apr 1.
10
Discovery of USP7 small-molecule allosteric inhibitors.USP7 小分子别构抑制剂的发现。
Bioorg Med Chem Lett. 2020 Oct 15;30(20):127471. doi: 10.1016/j.bmcl.2020.127471. Epub 2020 Aug 8.

引用本文的文献

1
Effect of deubiquitinases in head and neck squamous cell carcinoma (Review).去泛素化酶在头颈部鳞状细胞癌中的作用(综述)
Oncol Lett. 2025 Apr 23;29(6):307. doi: 10.3892/ol.2025.15053. eCollection 2025 Jun.
2
Deubiquitinases as novel therapeutic targets for diseases.去泛素化酶作为疾病的新型治疗靶点。
MedComm (2020). 2024 Dec 13;5(12):e70036. doi: 10.1002/mco2.70036. eCollection 2024 Dec.

本文引用的文献

1
Structural Insights into the Catalytic Mechanism and Ubiquitin Recognition of USP34.USP34 的催化机制和泛素识别的结构见解。
J Mol Biol. 2022 Jul 15;434(13):167634. doi: 10.1016/j.jmb.2022.167634. Epub 2022 May 16.
2
A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present).USP7 抑制剂的专利研究综述(2014 年至今)。
Expert Opin Ther Pat. 2022 Jul;32(7):753-767. doi: 10.1080/13543776.2022.2058873. Epub 2022 Mar 31.
3
MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11.
微小RNA-101-3p通过抑制USP47诱导的RPL11去泛素化来抑制癌细胞生长。
Cancers (Basel). 2022 Feb 15;14(4):964. doi: 10.3390/cancers14040964.
4
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.抑制去泛素化酶USP47作为治疗表达突变EZH2的血液系统恶性肿瘤的新型靶向疗法。
Leukemia. 2022 Apr;36(4):1048-1057. doi: 10.1038/s41375-021-01494-w. Epub 2022 Jan 17.
5
Deubiquitinases: From mechanisms to their inhibition by small molecules.去泛素化酶:从机制到小分子抑制。
Mol Cell. 2022 Jan 6;82(1):15-29. doi: 10.1016/j.molcel.2021.10.027. Epub 2021 Nov 22.
6
USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide.USP47 维持结直肠癌细胞的干性,并受小白菊内酯抑制。
Biochem Biophys Res Commun. 2021 Jul 12;562:21-28. doi: 10.1016/j.bbrc.2021.05.017. Epub 2021 May 21.
7
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.靶向 USP47 克服酪氨酸激酶抑制剂耐药性并根除慢性髓性白血病中的白血病干细胞/祖细胞。
Nat Commun. 2021 Jan 4;12(1):51. doi: 10.1038/s41467-020-20259-0.
8
The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy.泛素特异性蛋白酶 7(USP7)的新兴特性:癌症治疗的新靶点。
Drug Discov Today. 2021 Feb;26(2):490-502. doi: 10.1016/j.drudis.2020.10.028. Epub 2020 Nov 4.
9
USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2.USP47通过去泛素化核糖体蛋白S2对p53进行负调控来促进肿瘤发生。
Cancers (Basel). 2020 May 1;12(5):1137. doi: 10.3390/cancers12051137.
10
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.发现具有体内抗肿瘤活性的强效、选择性和口服生物可利用的 USP7 抑制剂。
J Med Chem. 2020 May 28;63(10):5398-5420. doi: 10.1021/acs.jmedchem.0c00245. Epub 2020 May 6.